HIGHLIGHTS
- who: Olga Krasnova from the Department of Neurosurgery, First Affiliated Hospital of Kunming Medical University, Kunming, China have published the paper: GALNT2 sustains glioma stem cells by promoting CD44 expression, in the Journal: (JOURNAL)
- what: Background, the authors aimed to explore the biological significance of GALNT2 in GBM tumorigenesis and development. cells were isolated into 96-well plates. In this study, all clinical glioma specimens were collected from the First Affiliated Hospital of Kunming Medical University. Rational screening GALNT2 specific inhibitor Considering the critical role that GALNT2 plays in promoting GBM progression and the downstream . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.